Context

• India’s healthcare system faces a difficult contradiction: private investment is essential for expanding capacity, yet excessive commercialisation can make medical care unaffordable and distort clinical priorities.
• The Parliamentary Standing Committee on Health and Family Welfare’s 176th Report brings this tension into sharp focus.
• With private hospitalisation costing far more than treatment in government facilities, the challenge is to create a healthcare system that attracts capital without allowing financial incentives to override medical necessity.

The High Cost of Private Healthcare

• The average cost of hospitalisation is ₹50,508 in private facilities, compared with ₹6,631 in government facilities.
• The disparity is similarly striking in childbirth, where average out-of-pocket expenditure is ₹37,630 in private facilities, against ₹2,299 in public facilities.
• The Committee has made 368 recommendations, including standardised package rates, mandatory pre-treatment cost estimates and greater transparency in hospital billing.
• It has also proposed regulating room tariffs and encouraging large corporate hospitals to cross-subsidise poorer patients and provide beds to AB-PMJAY beneficiaries at regulated rates.
• These proposals recognise that healthcare cannot be treated like an ordinary consumer market.
• A patient often lacks the expertise to determine whether a costly diagnostic test, prolonged admission or invasive procedure is genuinely necessary.

The Investment-Regulation Contradiction

• Hospitals require enormous expenditure on land, medical equipment, ICUs, laboratories, digital infrastructure and skilled personnel.
• Public hospitals alone cannot currently satisfy the country's demand for secondary and tertiary care.
• Foreign investors and private-equity funds can contribute capital, technology, managerial expertise and expansion capacity, particularly in Tier-2, Tier-3 and rural markets.
• Restrictive or unpredictable regulation could discourage investment and slow the creation of desperately needed infrastructure.
• The answer, therefore, is not to reject private capital but to distinguish between productive investment and potentially harmful concentration.
• Policymakers should ask whether an investment creates new capacity or merely acquires existing hospitals, whether it increases competition or promotes consolidation, and whether publicly supported hospitals have enforceable obligations towards poorer patients.

The Problem of Commercial Incentives

• Doctors and hospitals possess far greater knowledge than patients and can influence decisions about tests, procedures and treatment duration.
• This becomes particularly significant when hospitals operate under strong revenue incentives.
• High salaries for specialists, expensive equipment and premium infrastructure create substantial fixed costs.
• Pressure to increase occupancy, revenue per bed and procedure volumes can consequently influence institutional behaviour.
• This does not imply that doctors routinely recommend unnecessary treatment. Rather, systems shape incentives.
• Excessive commercialisation can encourage over-investigation, unnecessary admissions, excessive medication and procedures that may provide limited additional benefit.
• Greater screening can also identify abnormalities that might never have harmed the patient, triggering further tests and interventions.

The Way Forward

• Smarter Regulation, Not Blanket Controls
  • The proposed review of FDI in existing hospitals deserves consideration, but regulation should focus on its effects rather than the nationality of investors.
  • Domestic and foreign investors can both be profit-oriented, while foreign capital can also bring substantial benefits.
  • Similarly, linking hospital room charges to nearby three-star hotels may appear simple but is unlikely to solve the underlying problem.
  • Hospital rooms involve nursing, infection control and emergency support that hotel rooms do not.
  • Capping one component may simply encourage hospitals to increase charges elsewhere.
  • The more effective approach is to regulate the total cost of a treatment episode through transparent estimates, standardised packages, billing rules and audits.
  • Diagnosis-Related Groups (DRGs) provide one possible model by reimbursing hospitals through predetermined payments based on diagnosis and procedures rather than rewarding every individual service.
• Strengthening Public Healthcare
  • If government hospitals remain overcrowded, understaffed and difficult to access, patients will continue to depend heavily on expensive private providers.
  • India therefore needs stronger primary healthcare, preventive care and early diagnosis, alongside better-equipped public hospitals.
  • Public facilities should become a credible alternative rather than merely the destination of those who cannot afford private treatment.
  • Insurance schemes such as AB-PMJAY should also incentivise appropriate treatment rather than simply increasing procedure volumes.
  • Public funding should be linked to measurable standards of affordability, quality and patient outcomes.

Conclusion

• India does not face a choice between private healthcare and public healthcare. It needs both, but with clearly defined responsibilities.
• Private investment can expand capacity, introduce technology and improve services, while public healthcare must guarantee accessibility and provide a competitive alternative.
• The central principle should therefore be simple: capital may shape the capacity of the healthcare system, but medical need must shape its clinical priorities.
• India’s healthcare progress should ultimately be measured not by the volume of investment or the growth of medical tourism, but by whether citizens can enter a hospital with confidence that they will receive what they need, no more and no less.